WallStreetZenWallStreetZen

NASDAQ: ABOS
Acumen Pharmaceuticals Inc Stock Ownership - Who owns Acumen Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Acumen Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matt ZugaCFO Chief Business Officer2025-01-2328,902$1.72
$49.62kSell
Russell BartonChief Operating Officer2025-01-212,914$1.61
$4.69kSell
Derek M. MeisnerChief Legal Officer Corp Sec2025-01-213,418$1.59
$5.43kSell
Daniel Joseph OconnellChief Executive Officer2025-01-2112,619$1.59
$20.10kSell
Eric SiemersChief Medical Officer2025-01-213,219$1.59
$5.12kSell
Matt ZugaCFO Chief Business Officer2025-01-214,364$1.60
$6.99kSell
Eric SiemersChief Medical Officer2025-01-0310,859$1.85
$20.05kSell
Derek M. MeisnerChief Legal Officer Corp Sec2025-01-0311,122$1.84
$20.51kSell
Matt ZugaCFO Chief Business Officer2025-01-0313,235$1.84
$24.37kSell
Daniel Joseph OconnellChief Executive Officer2025-01-0347,778$1.84
$87.86kSell

1 of 2

ABOS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABOS insiders and whales buy or sell their stock.

ABOS Shareholders

What type of owners hold Acumen Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP24.65%14,932,063$19.71MInstitution
Robert D. Hardie6.37%3,859,141$5.09MInsider
Sands Capital Ventures Discovery Fund III LP5.64%3,417,075$4.51MInsider
Sands Capital Alternatives LLC5.64%3,417,075$4.51MInstitution
Franklin Resources Inc5.08%3,077,039$4.06MInstitution
Fmr LLC3.35%2,029,736$2.68MInstitution
Millennium Management LLC3.22%1,950,120$2.57MInstitution
Vanguard Group Inc2.79%1,689,351$2.23MInstitution
Knollwood Investment Advisory LLC2.69%1,628,510$2.15MInstitution
Pathstone Holdings LLC1.75%1,058,531$1.40MInstitution

1 of 3

ABOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABOS62.08%17.23%Net Selling
RPTX54.39%45.61%Net Selling
BYSI14.88%12.88%Net SellingNet Selling
VANI2.84%97.16%Net Buying
STRO65.81%18.19%Net SellingNet Selling
View Top Biotech Stocks

Acumen Pharmaceuticals Stock Ownership FAQ

Who owns Acumen Pharmaceuticals?

Acumen Pharmaceuticals (NASDAQ: ABOS) is owned by 62.08% institutional shareholders, 17.23% Acumen Pharmaceuticals insiders, and 20.69% retail investors. Robert D. Hardie is the largest individual Acumen Pharmaceuticals shareholder, owning 3.86M shares representing 6.37% of the company. Robert D. Hardie's Acumen Pharmaceuticals shares are currently valued at $4.86M.

If you're new to stock investing, here's how to buy Acumen Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.